RBP4 and Other metabolic disease: The expression levels were correlated with clinical markers of lipid and glucose metabolism, androgen status, as well as expression of genes related to glucose metabolism within adipose tissue, i.e., GLUT4, insulin degrading enzyme (IDE), and retinol-binding protein 4 (RBP4), all speculated to be involved in metabolic disease.